Alpha 2.0
Login Register
» Authors » Marianna David

Marianna David

Explore the profile of Marianna David including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 104
Followers 0
Related Specialties
General Medicine
History of Medicine
Hematology
Top 10 Co-Authors
Hajna Losonczy
Agnes Nagy
William Thomas
Gyorgy Pfliegler
Orsolya Toth
Andrew Chase
Raymond Dang
Robin J Russell-Jones
Chiara Vendramin
Jayanthi Alamelu
Published In
Orv Hetil
Blood
Genes Chromosomes Cancer
Affiliations
Soon will be listed here.
Recent Articles
1.
Characterization and treatment of congenital thrombotic thrombocytopenic purpura
Alwan F, Vendramin C, Liesner R, Clark A, Lester W, Dutt T, et al.
Blood . 2019 Feb; 133(15):1644-1651. PMID: 30770395
Congenital thrombotic thrombocytopenic purpura (cTTP) is an ultra-rare thrombomicroangiopathy caused by an inherited deficiency of a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13). There are...
2.
Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma
Alpar D, de Jong D, Holczer-Nagy Z, Kajtar B, Savola S, Jakso P, et al.
Genes Chromosomes Cancer . 2013 May; 52(9):785-93. PMID: 23720363
Multiple myeloma (MM) is a genetically heterogeneous disease with diverse clinical outcomes. Interphase fluorescence in situ hybridization (i-FISH) is the most commonly used approach to detect recurrent cytogenetic abnormalities in...
3.
[Questionnaire for assessing the risk of venous thromboembolism in hospitalized surgical and non-surgical patients in the 4th Hungarian antithrombotic guideline entitled "Risk reduction and treatment of venous thromboembolism"]
David M, Losonczy H, Udvardy M, Boda Z, Blasko G, Tar A, et al.
Orv Hetil . 2010 Aug; 151(34):1365-74. PMID: 20705551
A large proportion of hospitalized surgical and medical patients are at risk for venous thromboembolism. Depending on the type of surgical intervention, venous thrombosis develops in 15-60% of surgical patients...
4.
Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders
David M, Cross N, Burgstaller S, Chase A, Curtis C, Dang R, et al.
Blood . 2006 Sep; 109(1):61-4. PMID: 16960151
Fusion genes derived from the platelet-derived growth factor receptor beta (PDGFRB) or alpha (PDGFRA) play an important role in the pathogenesis of BCR-ABL-negative chronic myeloproliferative disorders (CMPDs). These fusion genes...
5.
[Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia]
Toth O, David M, Habon T, Nagy A, Keszthelyi Z, Kovacs N, et al.
Orv Hetil . 2005 Nov; 146(41):2121-5. PMID: 16304806
Introduction: In rare cases of thromboembolic diseases developing in young age, venous and arterial thromboembolism can occur simultaneously. Aims: To detect the venous and the arterial risk factors in a...
6.
[Results of imatinib therapy in late-stage chronic myeloid leukemia after treatment with interferon-alpha]
Molnar L, Nagy A, David M, Szomor A, Mehes G, Kovacs G, et al.
Orv Hetil . 2004 Jun; 145(17):901-7. PMID: 15170967
Background: Chronic myelogenous leukemia is characterised by the presence of Philadelphia translocation and consecutive expression of bcr-abl oncogene with enhanced tyrosine kinase activity, which is known to be the essential...